We have determined the first structure of a family 31 ␣-glycosidase, that of YicI from Escherichia coli, both free and trapped as a 5-fluoroxylopyranosyl-enzyme intermediate via reaction with 5-fluoro-␣-D-xylopyranosyl fluoride. Our 2.2-Å resolution structure shows an intimately associated hexamer with structural elements from several monomers converging at each of the six active sites. Our kinetic and mass spectrometry analyses verified several of the features observed in our structural data, including a covalent linkage from the carboxylate side chain of the identified nucleophile Asp 416 to C-1 of the sugar ring. Structure-based sequence comparison of YicI with the mammalian ␣-glucosidases lysosomal ␣-glucosidase and sucrase-isomaltase predicts a high level of structural similarity and provides a foundation for understanding the various mutations of these enzymes that elicit human disease.
Glycoside hydrolases play critical roles in biology ranging from digestion and decomposition of polysaccharides to biosynthesis of glycoproteins. Gene sequences of many thousands of these important enzymes have now been determined, and the corresponding enzymes have been grouped into families on the basis of sequence similarity (1) (2) (3) (4) (5) . 1 The ␣-glucosidases are a particularly important subset of these enzymes, both in primary metabolism and in glycoconjugate biosynthesis and processing. These enzymes are principally found in families 13 and 31 and, to a lesser extent, in families 4 and 63. Family 13 contains a wide range of glucosideprocessing enzymes, including the ␣-amylases and cyclodextrin glucanotransferases. Correspondingly, enzymes of this family have attracted considerable attention, with numerous mechanistic studies and with three-dimensional structures having been known for some 20 years. By contrast, family 31 has received relatively little attention despite its importance and the number of different activities represented from a range of organisms, including animals, plants, and microorganisms (6, 7) . This family contains such important ␣-glucosidases as the human lysosomal ␣-glucosidase, a deficiency of which results in Pompe's disease (also known as glycogen storage disease type 2 or acid maltase deficiency, the marked feature of which is the accumulation of glycogen in heart and skeletal muscle cells); the endoplasmic reticulum glucosidase II, which plays a key role in glycoprotein processing and folding; and the digestive enzyme sucrase-isomaltase, which is the target of inhibition by the anti-diabetes drugs acarbose and miglitol. It also contains ␣-xylosidases, isomaltosyltransferases, and the mechanistically interesting ␣-glucan lyases, which carry out an elimination reaction rather than hydrolysis.
Despite the importance of this family, mechanistic insights are limited. The enzymes are known to be retaining ␣-glycosidases, which hydrolyze the glycosidic bond with net retention of anomeric configuration via an acid/base-catalyzed mechanism involving a covalent glycosyl-enzyme intermediate. Through a range of studies involving affinity labeling, trapping of reaction intermediates, and site-directed mutagenesis, the catalytic nucleophile has been identified as an aspartic acid residue within the consensus sequence WIDMNE (Asp 224 for the Aspergillus niger ␣-glucosidase) (6 -14) . On the basis of sequence comparisons and kinetic analysis of mutants, the acid/base catalyst has been tentatively assigned as an aspartic acid residue (Asp 647 in the Schizosaccharomyces pombe ␣-glucosidase) (14) . Highly oxocarbenium ion-like transition states are suggested by the large ␣-secondary kinetic isotope effects seen for both ␣-glucosidases and the ␣-glucan lyase (15) (16) (17) as well as by the tight binding observed for aza sugar transition state analog inhibitors such as nojirimycin and acarbose (17) (18) (19) (20) (21) . However, a key missing component, which would be particularly important for inhibitor design, is the three-dimensional structure of any member of this family.
Inspection of the complete genome sequence of Escherichia coli revealed that it contains two genes encoding enzymes from family 31, yicI and yihQ, but no information was available concerning the function of each gene product. These proteins should be good model enzymes for both mechanistic and struc-tural analyses, being devoid of the post-translational modifications that can complicate such studies in proteins from higher order organisms. They are therefore attractive targets for investigation.
This study describes the cloning, expression, and kinetic and mechanistic characterization and also the three-dimensional structural analysis of one of these two enzymes, YicI. The results obtained confirm previous predictions of key catalytic residues in this family and provide a structural framework both for the design of new ␣-glucosidase inhibitors and for the understanding of lysosomal ␣-glucosidase mutations that result in Pompe's disease. 2 
MATERIALS AND METHODS

General Procedures-All
1 H NMR spectra were recorded at either 200 or 300 MHz and 19 F NMR spectra at 188 or 282 MHz using a Bruker AC-200 or AV-300 spectrometer. 19 F NMR spectra were referenced to CF 3 COOH. Mass spectra of small molecules were recorded using a PE-Sciex API 300 triple quadrupole mass spectrometer (Sciex, Thornhill, Ontario, Canada) equipped with an electrospray ionization ion source. The Bradford assay (23) was used for the determination of protein concentration. Agarose gels (0.8% (w/v); Bio-Rad) were used for all electrophoresis of DNA. SDS-PAGE (24) was performed to analyze the homogeneity of proteins.
␣-D-Xylopyranosyl fluoride was synthesized according to a published method (25) . p-Nitrophenyl ␣-D-xylopyranoside (pNP␣Xyl) 3 was purchased from Aldrich. Synthesis of (5S)-and (5R)-5-fluoro-␣-D-xylopyranosyl fluorides (ax-5F␣XF and eq-5F␣XF, respectively) was achieved via radical bromination of per-O-acetyl-␣-D-xylopyranosyl fluoride, followed by displacement with fluoride using AgBF 4 and then deprotection using NH 3 /MeOH. Full details will be provided elsewhere. 4 Pepsin (from porcine mucosa) was purchased from Roche Applied Science. Yeast extracts and Tryptone were purchased from Difco. 40% acrylamide/N,NЈ-methylenebisacrylamide and TEMED were purchased from Bio-Rad. All other chemicals and reagents were purchased from Sigma unless indicated otherwise.
Cloning of the yicI Gene-The genomic DNA of E. coli K12 was isolated using a QIAmp tissue kit (QIAGEN Inc.). The yicI gene was amplified by PCR with Pwo polymerase (Roche Applied Science) using the chromosomal DNA of E. coli as a template and the two synthetic primers YicITOP (5Ј-CAG AAC TAA GGA ACG CAT ATG AAA ATT AGC-3Ј) and YicIEND (5Ј-ATC AAG CTC GAG CAA CGT AAT TGT CAG CGC-3Ј), which were designed based on the sequence of the yicI gene (GenBank TM /EBI accession number AE000443). The PCR product was digested with NdeI and XhoI and ligated with pET29a (Novagen) that had been digested with the corresponding restriction enzymes. After sequence analysis, one clone without any PCR error was designated as pET29YICI and was used for the production of His 6 -tagged YicI protein. The synthesis of PCR primers and the analysis of DNA sequences were carried out by the Nucleic Acid and Peptides Service Unit in the Biotechnology Laboratory at the University of British Columbia.
Expression and Purification of YicI-Plasmids containing the yicI gene (pET29YICI) were transformed into E. coli BL21(DE3), and the resulting cells were cultured overnight at 37°C in 1 liter of LB medium containing 20 g/ml kanamycin. The overnight culture was induced directly by addition of 0.3 mM isopropyl ␤-D-thiogalactopyranoside and grown for a further 5 h. The cell pellet was harvested and resuspended in 50 mM Tris-HCl (pH 8.0) containing 5 mM imidazole and 300 mM NaCl. The cell suspension was passed twice through a French press at 5°C and centrifuged at 10,000 ϫ g for 30 min, and the soluble extract was purified by nickel chelation chromatography. The protein was then dialyzed against 50 mM phosphate buffer (pH 7.0) and stored at 4°C.
The tryptic fragments of the protein were analyzed by electrospray ionization mass spectrometry to confirm the identity of the protein. The protein (1 mg/ml) was incubated with 10 units of trypsin in 1 ml of phosphate buffer (pH 7.0) for 1 h. The resulting digest was subjected to liquid chromatography/electrospray ionization mass spectrometry analysis, and masses of fragments were analyzed.
Enzyme Kinetics-All experiments were carried out at 37°C in 0.05 M phosphate buffer (pH 7.0) containing 0.1% bovine serum albumin unless indicated otherwise. Michaelis-Menten parameters for the pnitrophenyl glycosides were measured by monitoring the release of p-nitrophenol in the presence of enzyme at 400 nm with a Varian Cary 300 Bio UV-visible spectrometer equipped with a circulating water bath. Cuvettes of either 1-or 0.1-cm path length were used. The typical substrate concentration range employed was 0.3-3 ϫ K m . The difference in extinction coefficient (⌬⑀) between p-nitrophenyl glycoside and p-nitrophenol at 400 nm, pH 7.0, and 37°C was determined by measuring the difference in absorbance between fixed equal concentrations of each pair of p-nitrophenols and p-nitrophenyl glycosides. Kinetic parameters were obtained by direct fit of the data to the MichaelisMenten equation using the software GraFit 4.0 (73) . Kinetic parameters for ␣-D-xylopyranosyl fluoride were determined by monitoring the release of fluoride from a range of substrate concentrations using an Orion 96-09 combination fluoride ion electrode interfaced to a computer running LoggerPro software (Vernier Software Ltd.). Initial rates were used for the determination of kinetic parameters, which were obtained by direct fit of the data to the Michaelis-Menten equation using GraFit 4.0. Initial rates of hydrolysis of ax-5F␣XF and eq-5F␣XF by YicI were identical at all concentrations of ax-5F␣XF (0.1-2 mM) and eq-5F␣XF (0.1-1.2 mM) assayed. This rate was taken as the V max value for each substrate, and each k cat value was calculated from these V max values by dividing each V max by the corresponding enzyme concentration.
pH Dependence Studies-Measurement of the pH-dependent activity of YicI was carried out using ␣-D-xylopyranosyl fluoride as substrate by monitoring fluoride ion release. The following buffers were used: sodium acetate (pH 4.0 -5.5), MES (pH 6.0), MOPS (pH 6.5-7.5) and glycylglycine (pH 8.0 -8.5). All buffers were 0.05 M in strength and contained 0.05 M NaCl. The substrate depletion method was employed as follows. A solution of substrate (0.02 mM, ϳ50-fold lower than the K m value) was preincubated at 37°C, and then the release of fluoride ion after addition of the enzyme was monitored using an Orion 96-09 combination fluoride ion electrode interfaced to a computer running the LoggerPro software until at least 80% depletion of substrate had occurred. Appropriate controls confirmed that, at 37°C, YicI was stable over the reaction time at each pH value studied. Fitting the data to a first-order rate equation (GraFit 4.0) yielded an apparent rate constant for the reaction, from which the k cat /K m value for each substrate was calculated by dividing that rate constant by the concentration of YicI. The k cat /K m values obtained were then plotted versus pH and fitted to the appropriate curve using GraFit 4.0, thereby yielding apparent pK a values.
Inhibition Studies-Inhibition studies were performed by measuring enzyme activity in the presence of various concentrations of each inhibitor using pNP␣Xyl as substrate. YicI (preincubated at 37°C) was added to 200 l of buffer solution containing pNP␣Xyl and varying amounts of inhibitors (also preincubated at the corresponding temperature). The release of p-nitrophenol was monitored spectrophotometrically at 400 nm. The experiments were repeated at different concentrations of pNP␣Xyl. A Dixon plot of 1/v versus inhibitor concentration for each substrate concentration intersects a line given by 1/V max at an inhibitor concentration equal to ϪK i .
Inactivation Kinetics-For analysis of inactivation kinetics, the enzyme (final concentration of 0.2-3.6 mg/ml) was preincubated with a range of concentrations of ax-5F␣XF or eq-5F␣XF at 37 or 10°C. 10-l aliquots of the sample were withdrawn at time intervals and added to 500 l of 3 mM pNP␣Xyl pre-equilibrated at the appropriate temperature in the UV-visible spectrometer. The residual enzyme activity at each time interval at each concentration of inactivator was measured in this way. Pseudo first-order rate constants at each inactivator concentration (k obs ) were determined by fitting each curve to a first-order rate equation. Values for the inactivation rate constant (k i ) and the inactivator dissociation constant (K i ) were determined by fitting k obs values and inhibitor concentrations to the following equation:
Reactivation of the inactivated enzyme was carried out as follows. Enzyme (100 l, 0.30 mg/ml) fully inactivated by the inactivator at 10°C was concentrated using 10-kDa nominal cutoff centrifugal concentrators (Amicon Corp., Danvers, MA) to a volume of ϳ40 l and diluted with 1000 l of buffer. This was repeated twice, and the retentate was diluted to a final volume of 100 l. The inactivated enzyme was then incubated at 37°C, and reactivation was monitored by removal of aliquots (10 l) at appropriate time intervals and assayed as described above. Measured activities were corrected for decreases in activity due to denaturation over this time course using data for non-inactivated control samples. The reactivation rate constant (k react ) was determined by fitting the data to a first-order rate equation as described above.
Crystallization, Data Collection, and Processing-All YicI crystals used in this study were grown using a protein concentration of 10 mg/ml, with 1 l of purified protein mixed with 1 l of reservoir solution in a hanging drop experiment. Crystal form 1 was obtained with Crystal Screen II (26) solution 47 (100 mM sodium acetate (pH 4.6) and 2 M ammonium sulfate) at 18°C. Crystal form 2 was obtained with Zeelen Screen (27) solution 39 (100 mM Tris (pH 8.5), 15% (w/v) polyethylene glycol 1500, and 5% (v/v) 2-methyl-2,4-pentanediol) at 8°C. During optimization of the growth of crystal form 1, it was realized that the original screening solution had undergone a pH shift during storage and that the crystals grew at pH 6.5. Both crystal forms were flashfrozen in liquid nitrogen for data collection at 100 K. Crystal form 1 was cryoprotected using mother liquor supplemented with 100 mM MOPS (pH 6.5) and 16% (w/v) glycerol. Crystal form 2 was cryoprotected using mother liquor supplemented with a final concentration of 25% (v/v) 2-methyl-2,4-pentanediol. Data for all native data sets and the holmium derivative were collected on an ADSC Q210 detector at beamline 8.2.1 at the Advanced Light Source (Berkeley, CA). Data for the lanthanum and p-chloromercuribenzoate data sets were collected on a MAR 345 detector using an in-house CuK ␣ source. Diffracted intensities were evaluated using DENZO and SCALEPACK (28) and MOSFLM and SCALA (29) . Various data manipulations were accomplished using the CCP4 program suite (29) . Data collection statistics and derivatization details are given in Tables I and II . Crystals of the YicI⅐eq-5F␣XF complex were obtained in a short 3-min soak using crystal form 1 and 0.5 mM eq-5F␣XF in cryoprotection buffer.
Structure Phasing and Refinement-The structure was solved using both multi-wavelength anomalous dispersion and multiple isomorphous replacement phases with the COMBINE procedure in SOLVE (30) . Briefly, multi-wavelength anomalous dispersion phases from the holmium derivative were combined with multiple isomorphous replacement phases obtained using the highly redundant lanthanum derivative as an anomalously scattering "native" data set and the p-chloromercuribenzoate crystal soak as an isomorphous derivative. The mean figure of merit following this procedure was 0.39. Density modification using DM (29) improved the map enough to be able to assign a rough C-␣ trace for one monomer, which was then utilized to find the noncrystallographic symmetry operators. Phase extension to 2.2 Å with 6-fold averaging was performed using RESOLVE (30) . The model output from RESOLVE contained ϳ85% of the structure, with matched sequence assignment for 60% of the side chains. The remainder of the model was built manually using XFIT (31). Crystal form 2 was solved by molecular replacement with MOLREP (32) using the crystal form 1 hexamer as the search model. Refinement of all data sets was achieved using CNS (33) and REFMAC (34), with full statistics provided in Table   II . Ligand topologies and restraints were generated using the PRODRG server (35) . No non-crystallographic symmetry constraints or restraints were used during refinement.
RESULTS AND DISCUSSION
Sequence Alignment Analysis-The hypothetical protein encoded by the yicI gene from E. coli shows sequence similarity of 50% or more to hypothetical proteins from a range of organisms as well as to known glycosyl hydrolase (GH) family 31 enzymes (Fig. 1) . It also shows 20 -29% similarity to mammalian, plant, and fungal ␣-glucosidases and plant ␣-xylosidases and 20% similarity to ␣1,4-glucan lyases from family 31. The consensus sequence surrounding the catalytic aspartate nucleophile in this region of plant, mammalian, and fungal enzymes, including ␣-glucosidases and ␣-xylosidases, is WiDMnE, with a slight variation for ␣1,4-glucan lyases to WiDMnX (where X is V or T). However, bacterial proteins are known to have the sequence KTDFGE and are absolutely invariant. These clear distinctions between amino acid sequences of family 31 enzymes of higher organisms and bacteria suggest that the bacterial proteins took a different path early in the evolution of GH family 31 (36, 37) .
Substrate Specificity-To investigate the enzyme activity of the YicI protein (see "Materials and Methods" for cloning, overexpression, and purification), 12 different glycoside substrates were incubated with the protein in 0.05 M phosphate buffer (pH 7.0) at 37°C. As expected from the high sequence similarity to the GH family 31 ␣-xylosidase from Lactobacillus pentosus, the YicI protein rapidly hydrolyzed pNP␣Xyl and ␣-D-xylopyranosyl fluoride as substrates. Lower but significant activity was observed with p-nitrophenyl ␣-D-glucopyranoside, whereas neither the aryl ␣-glycosides of sugars such as galactose, mannose, and arabinose or any ␤-glucosides were hydrolyzed at all (Table  III) . Similarly, neither maltose nor maltotriose was cleaved, although the recent study of Okuyama et al. (22) showed that isoprimeverose (Xyl-␣(1,6)-Glc) is an excellent substrate, consistent with the expected role of this enzyme in xyloglucan degradation. Okuyama , on the activity of YicI were examined, and none of these affected the rate of hydrolysis of pNP␣Xyl. Measurement of the pH-dependent activity of YicI was performed using ␣-D-xylopyranosyl fluoride as a substrate. A classical bell-shaped dependence of k cat /K m on pH was observed as expected, indicating at least two essential, ionizable groups in the free enzyme (Fig. 2) . The two apparent pK a values are pK a1 ϭ 4.9 Ϯ 0.2 and pK a2 ϭ 7.9 Ϯ 0.1, with an estimated pH optimum of 6.4. These presumably correspond to the nucleophile Asp 416 and the acid/base catalyst Asp 482 , respectively. Reversible Inhibitors of YicI-Three different reversible inhibitors were tested with YicI (Fig. 3 ). Among these, 1-deoxyxylonojirimycin had the highest potency (K i ϭ 0.9 M), with the gluco analog 1-deoxynojirimycin (130 M) binding almost 50-fold more weakly, consistent with the much higher rates of hydrolysis of xylosides compared with glucosides. Indeed, the ␣-glucosidase inhibitor acarbose was completely non-inhibitory. The 1-aza sugar xyloisofagomine bound more weakly (176 M) compared with the 5-aza sugar, consistent with previous observations on aza sugar inhibitory preferences (40) .
Inactivation of YicI with Mechanism-based Inactivators ax-5F␣XF and eq-5F␣XF-Two new mechanism-based inactivators (ax-5F␣XF and eq-5F␣XF) were designed, synthesized, and tested (Fig. 3) . Compounds of this class are designed to react as substrates, but form a relatively stable 5-fluoroxylosylenzyme intermediate, which hydrolyzes only slowly; thus, they often behave as time-dependent inactivators. However, no timedependent inactivation was observed when ax-5F␣XF was incubated with YicI at 37°C, and aliquots were removed for assay of activity. However, the activity measured was lower than that in the control reaction containing no inhibitor and was concentration-dependent. The inhibition observed must be due to ax-5F␣XF carried over in the aliquot for assay, suggesting that ax-5F␣XF acts as a tight binding, reversible inhibitor. This behavior is reminiscent of that seen upon reaction of 5-fluoro-␣-glycosyl fluorides with ␣-glycosidases, where apparent tight binding was also observed (12, (41) (42) (43) , but was found to be due to the accumulation of a glycosyl-enzyme intermediate that turns over on a time scale shorter than the assay time. Thus, ax-5F␣XF was tested as an apparent competitive reversible inhibitor, and the apparent K i Ј value was determined to be 9.8 M.
The equatorial epimer eq-5F␣XF behaved likewise, with a K i Ј value of 0.45 M revealing even tighter apparent binding.
To confirm that this rapid inactivation was due to the accumulation of the covalent intermediate, reaction mixtures of both samples were subjected to analysis by electrospray ionization mass spectrometry, which revealed that the mass of the protein (89,094 Ϯ 8 Da) increased by 157 Da (reaction with ax-5F␣XF) and 158 Da (reaction with eq-5F␣XF). This is in agreement, within error, with the expected difference upon addition of the mass of a 5-fluoroxylosyl unit (151 Da) from ax-5F␣XF and eq-5F␣XF. The labeling of YicI by these two reagents indicates that the inhibition was indeed due to the accumulation of the covalent intermediate.
Time-dependent inactivation was indeed measured when reactions were carried out at a lower temperature, where turnover was slowed (Fig. 4) . Even though the inactivation was not complete at low concentrations of inactivators, the initial phase of inactivation followed pseudo first-order kinetics in both cases. Inactivation kinetics were fitted to the following simple model (Reaction 1).
The apparent first-order rate constants (k obs ) at each concentration of each inactivator were fitted to the expression k obs ϭ Ϫ1 and K i ϭ 0.31 Ϯ 0.06 mM were measured for eq-5F␣XF. The kinetic competence of the intermediates formed was assessed by dialyzing excess inactivator from each inactivated enzyme sample at 10°C and then monitoring the reactivation of each inactivated enzyme by taking aliquots and measuring activity at a series of time intervals at 37°C. The reactivation for both samples followed pseudo first-order kinetics (Fig. 4, C and D) and yielded rate constants of k react ϭ (3.2 Ϯ 0.4) ϫ 10 Ϫ3 s Ϫ1 for ax-5F␣XF and (3.2 Ϯ 0.1) ϫ 10 Ϫ4 s Ϫ1 for eq-5F␣XF at 37°C, proving that inactivation occurred through the normal enzymatic reaction mechanism.
Rates of enzyme-catalyzed hydrolysis of each 5F␣XF substrate at 37°C were measured using a fluoride electrode at a series of substrate concentrations. In each case, the enzymatic reaction continued at a constant rate until almost all of the substrate had been consumed, indicating very low K m values for each compound. These observations are reminiscent of what a ⌬⑀ of 4-nitrophenol at pH 7.0 was measured to be 9.13 Ϯ 0.02 mM Ϫ1 cm Ϫ1 . Rates were calculated using this value.
TABLE III Hydrolysis of various substrates by the YicI protein from E. coli
was seen during the reaction of ␣-glycosidases with 5-fluoro-␣-glycosyl fluorides (12, (41) (42) (43) and consistent with the low K i Ј values measured since the K m value of each compound as substrate should be equal to its K i Ј value as inhibitor. The turnover number (k cat ) was determined from the slope of these plots of fluoride release versus time, yielding k cat ϭ (2.16 Ϯ 0.02) ϫ 10 Ϫ3 s Ϫ1 for ax-5F␣XF and (1.22 Ϯ 0.08) ϫ 10 Ϫ4 s Ϫ1 for eq-5F␣XF. The similarity of these values to the reactivation rate constants confirmed that the same process was being monitored in the two cases.
The catalytic nucleophile was identified as Asp 416 within sequence FKTDFG by liquid chromatography/tandem mass spectrometry analysis of proteolytic digests of YicI trapped as its glycosyl-enzyme intermediate with eq-5F␣XF. Full experimental details are provided in the Supplemental Material.
Overall Architecture and Oligomerization of YicI-Crystallization trials yielded two different crystal forms of YicI, each possessing six molecules of YicI/asymmetric unit, related by point group 32 non-crystallographic symmetry. The hexamer is formed from two trimeric structures stacked slightly out of register, as is seen from the two views in Fig. 5 (A and B) . This observation of a YicI hexamer is in agreement with results from native PAGE and dynamic light scattering analysis (data not shown) and is consistent with the results of Okuyama et al. (22) based on gel filtration chromatography. Structure refinement statistics are listed in Table II . The root mean square deviation between the crystal form 1 and form 2 hexamers is 0.46 Å 2 for 18,552 common backbone atoms (0.29 Å 2 between both crystal form 1 structures), as calculated using the "magic fit" and "refine fit" procedures in the Swiss-Pdb viewer (44) . Using an identical procedure, the root mean square deviations between chain A of crystal form 2 and the other chains of the hexamer range between 0.2 and 0.28 Å 2 for backbone atoms. These values are consistent with YicI adopting a highly similar conformation in all of the protomers in this study, with the only significant exception being due to a partial disorder of some active-site loops (induced by crystal packing) in monomer D of crystal form 1. The total buried surface area per monomer upon oligomerization was calculated to be 3913 Å 2 using CNS (33), a significantly high value in keeping with a physiologically relevant oligomer. Remarkably, although YicI contains 13 Cys residues/monomer, the structure has no disulfide bonds (although a distance of 3.8 Å between the sulfur atoms of Cys 343 and Cys 412 suggests that one may be possible in structurally related homologs).
The structure of a YicI monomer can be divided into five distinct domains: the N-terminal domain (domain N, residues 1-245), the catalytic domain (residues 245-349 and 387-588), an insert in the catalytic domain (residues 349 -387), a proximal C-terminal domain (residues 588 -665), and a distal Cterminal domain (residues 665-772). A representation of these individual domains is provided in Fig. 6 .
The N-terminal Domain-Domain N is predominantly composed of ␤-strands, folding together to form an extensive antiparallel ␤-sandwich. Loops protruding from domain N form several key intermolecular interactions within the hexamer. Residues 1-13 form a small U-shaped loop that protrudes into the active site of an adjacent monomer, whereas a loop formed by residues 37-52 contacts a second distinct active site in the hexamer. The largest loop of domain N (residues 71-90) contacts the catalytic domain of both its own and other monomers and appears to be important for hexamer formation. The region formed by residues 164 -197 of domain N makes several contacts with the active site of its own monomer. First, a short loop formed by residues 164 -172 packs against ␣6 of the catalytic domain, and the following residues (residues 176 -182) then form the end strand of the domain N ␤-sandwich. Second, a loop comprising residues 183-197 contacts the catalytic domain and forms part of the edge of the active site. Domain N shows structural similarity to domains from other CAZy (carbohydrate-active enzymes). Database entries, with Dali (45) returning significant Z-scores of 5.8 and 5.6 (12 and 8% sequence identity, respectively) for domains within glucoamylase (Protein Data Bank code 1lf6) (46) and chondroitin AC lyase (Protein Data Bank code 1rw9) (47), respectively. These structurally similar domains have been proposed to play a role in carbohydrate binding (48) . An interesting feature of these homologous domains is that they are placed at different points in the protein sequence, preceding the catalytic domain in glucoamylase and following it in chondroitin AC lyase. This domain is also found in other GH13 family members and, like YicI, can be seen to associate with the active site of an opposing monomer when present in a multimeric structure (49) . Any role of domain N in substrate binding may come from direct effects of loop residues contributing to the various active sites of the hexamer or from more indirect structural effects due to its close interaction with regions of the catalytic domain.
The Catalytic Domain-The catalytic domain is composed of a ␤ 8 ␣ 8 -barrel, very similar to that of the GH13 family members, with an additional mixed (␣ ϩ ␤)-domain inserted between ␤3 and ␣3. The secondary structure of the catalytic domain and a 
FIG. 3. Chemical structures and K i /K i values of inhibitors (A) and mechanism-based inactivators (B).
Structure of a Family 31 ␣-Glycosidase
sequence alignment with selected GH31 family members are provided in Fig. 1 . CAZy clans GH-A, GH-D, GH-H, and GH-K have also been shown to contain catalytic ␤ 8 ␣ 8 -domains (1), all of which place the active-site nucleophile on ␤4, and YicI appears to be consistent with this (see below). The ␤ 8 ␣ 8 -barrel is typical of this fold, although ␣5 is replaced by a loop that contacts domain N, identical to some members of GH13 (50) . Helix ␣8 continues into another ␣-helix, with the conserved residue Pro 570 forming an ϳ60°kink between the two helices. In keeping with the YicI substrate specificity for ␣-glycosidic bonds, the catalytic domain structure matches best with GH13 ␣-amylase II (Protein Data Bank code 1bvz) (49), with a Dali score of 17.3 for a 253-amino acid overlap (12% identity). Both YicI and ␣-amylase II possess an inserted domain between ␤3 and ␣3 (residues 349 -387 in YicI), with the ␤-sheet of both inserts overlaying well, but showing structural differences in the loop regions. This domain is known to vary with substrate specificity (51) . As well as contributing residues to the active site of YicI, this insert is also involved in monomer/ monomer packing and forms part of the central "pore" of the hexamer. Conserved sequence regions I-VII of GH31 family members (52) are shown mapped to the YicI structure in Fig. 1 ; one of these regions, region II, is in the ␤3-␣3 insert. Regions I and III-VI are located in the main ␤ 8 ␣ 8 -fold and contribute some of the active-site residues. Region VII is located on the ␣8/continuing helix interface and is involved in packing of the catalytic domain against the C-terminal domains.
The C-terminal Domains-The proximal C-terminal domain possesses a mixed (␣ ϩ ␤)-fold consisting of a central antiparallel ␤-sheet (that also harbors a long twisted ␤-hairpin) and a small loop with two short helical turns. The loop region packs against the start of the catalytic domain, whereas the sheet contacts helices ␣6, ␣7, and ␣8 of the ␤ 8 ␣ 8 -barrel. The contacts between this region and the barrel are particularly hydrophobic and may indicate a role for the proximal C-terminal domain in protecting the barrel from bulk solvent. The fold of this domain also appears to share structural homology with other CAZy Database entries, with Dali returning Z-scores of 5.4 with trehalose synthase (Protein Data Bank code 1iv8; 60-amino acid overlap; 10% identity) (53) and 5.3 with ␣-amylase II (Protein Data Bank code 1bvz; 62-amino acid overlap; 10% identity) (49) . This domain plays a role in forming the YicI hexamer, associating with the same domain from the opposing monomer in the dimeric ring. The homologous domain from ␣-amylase II is not responsible for dimer formation and is solvent-exposed.
The distal C-terminal domain is located at the points of the triangle-shaped hexamer and makes its major interaction with the rest of the structure at the ␤ 8 ␣ 8 -conserved region VII, as noted above. This domain plays no role in hexamer formation and may be responsible for binding carbohydrates due to its similarity to carbohydrate-binding domains. The fold consists of an antiparallel ␤-sandwich, comprising two sheets of five ␤-strands each, strands 2 and 6 running parallel to each other. The highest Dali scores obtained were 4.8 for an ␣-L-arabinofuranosidase (Protein Data Bank code 1pz2; 77-amino acid overlap; 6% identity) (54), 4.8 for a ␤-xylosidase (Protein Data Bank code 1px8; 69-amino acid overlap; 10% identity) (55) , and interestingly, 4.7 for the xylan-binding domain of a xylanase (Protein Data Bank code 1xbd; 61-amino acid overlap; 20% identity) (56) . Despite the similar Z-scores, the structural homology to code 1pz2 is best, as this overlaps, with all 10 ␤-strands matching, and also shows two parallel strands in the same location as those of YicI. Carbohydrate-binding domains often bind divalent cations for structural stability, and the location of the holmium-binding site in this domain in our heavy atom soaking trials may be indicative of the ancestry of the distal C-terminal domain, although it appears that only water is bound in this pocket in the native electron density maps.
Structure of the Active Site-As is typical of a ␤ 8 ␣ 8 -structure, the active site is positioned at the C-terminal end of the barrel (Figs. 6 and 7) . The ends of the barrel ␤-strands and the loops that follow them contribute the major part of the active site (residues 271-280, 301-316, 342-352, 413-420, 462-468, 477-485, 508 -518, and 537-544), with additional regions from the barrel insert (residues 378 -382) and three different N-terminal domains (residues 183-195 from the corresponding monomer and residues 4 -10 and 37-51 from two distinct monomers of the hexamer). The formation of the active site from several of the monomers suggests that oligomerization of YicI may play a functional role in substrate binding as well as in stabilization of the protein fold. The active-site pocket is easily accessible, largely via a cavity in the middle of the long edge of the hexamer (where the two trimeric rings meet) and also, to a lesser extent, via a cavity extending from the central pore of the hexamer.
GH family members with a ␤ 8 ␣ 8 -fold are known to place the active-site nucleophile on ␤4 and the acid/base on differing ␤-strands of the barrel (57) GH13 and the reaction catalyzed is similar (␣-retaining), the acid/base in YicI is Asp 482 on ␤6, whereas for GH13 members, the acid/base is a glutamic acid and is located on ␤5. This placement of the acid/base on ␤6 is more similar to enzymes from GH18 (chitinases), which catalyze a ␤-retaining reaction. However, the important functional characteristic is the distance between the two catalytic carboxylic acid oxygens: ϳ6 Å in YicI and ϳ6 Å in GH13 (Protein Data Bank code 1UH2) (48) . The longer distance of at least 7 Å in GH18 (Protein Data Bank code 1CTN) (58) is consistent with the fact that GH18 chitinases follow a different mechanism in which the substrate amide functions as the nucleophile, with the adjacent carboxylate assisting it in that role.
The Interestingly, approximately half of these active-site hydrophobic residues originate from elements outside the ␤ 8 ␣ 8 -fold, a fact not immediately obvious when looking at sequence alignments containing the seven classical GH31 motifs (52) . This may have substantial consequences for specificity within homologs of different oligomeric structure, such as human sucrase-isomaltase, which is predicted to be a dimer (59) .
Binding of eq-5F␣XF-Soaking of the form 1 crystals in 0.5 mM eq-5F␣XF for 3 min resulted in clear ring-shaped electron density (Fig. 7A) , visible at full occupancy in three of the active sites (monomers A, B, and C) and at partial occupancy in monomer E. Modeling of the sugar analog into this density confirmed that the compound has indeed formed a covalent bond between C-1 of the sugar and O-␦2 of Asp 416 , with loss of the fluoride from C-1. The sugar forms a covalent bond with the enzyme, with a bond distance of 1.45 Å and a C-␥-O-␦2-C-1 bond angle of 116°modeled during refinement. Whereas free eq-5F␣XF in solution has been shown to adopt a 4 C 1 chair conformation, the covalently bound ␤-linked sugar is found in a 1 S 3 skew boat conformation (Fig. 8) . This flipped conformation could simply be a response to the strong anomeric effects at C-5 and C-1 from F-5 and the enzyme carboxyl group, respectively, both wanting to adopt axial placements. However, precedent with a similar intermediate trapped in an ␣-mannosidase suggests that this conformation is determined by interactions with the enzyme and is mechanistically relevant (60) . It is very interesting that this conformation for the ␤-D-xylopyranosylenzyme intermediate is identical to the conformation seen for the bound ␤-glycoside substrate in the uncleaved Michaelis complexes of several ␤-glycosidases (61) (62) (63) . Such structures of Michaelis complexes have typically been achieved by soaking or co-crystallization of an uncleavable substrate analog such as a thioglycoside with wild-type enzyme or a natural substrate with an inactive mutant enzyme. In each case, the ␤-glycoside substrate has been found in a 1 S 3 conformation, consistent with the dictates of stereoelectronic theory (64) or simply minimizing steric repulsive interactions during nucleophilic attack as discussed (61) . The observation of this same conformation for our ␤-linked glycosyl-enzyme intermediate implies that the same stereoelectronic forces are coming into play as in the cleavage of the ␤-glycoside substrate. It therefore appears that the same conformational itinerary ( 4 C 1 3 1 S 3 3 4 H 3 1 S 3 3 4 C 1 ) is followed by ␣-glycosidases and ␤-glycosidases in this case, but starting at different points on the path.
The eq-5-fluoroxylosyl adduct makes several important contacts with the protein and conserved water molecules. The presence of the bulky Phe 277 near C-5 of the adduct may provide an explanation for the very low ␣-glucosidase activity of YicI. This phenylalanine residue is situated at the end of ␤1 and appears to be present in an insert that is not found in the . The two structures are represented in ball-and-stick format and colored as follows: YicI carbon atoms, yellow; Cel5A carbon atoms, blue; oxygen atoms, red; and fluorine atoms, magenta. The two sugar molecules can be seen to overlap well, both adopting a 1 S 3 skew boat conformation. B was prepared using Molscript (70) and Raster3D (71) .
